Annual Retained Earnings
-$580.53 M
-$72.89 M-14.36%
31 December 2023
Summary:
Astria Therapeutics annual retained earnings is currently -$580.53 million, with the most recent change of -$72.89 million (-14.36%) on 31 December 2023. During the last 3 years, it has fallen by -$319.64 million (-122.51%). ATXS annual retained earnings is now -985.19% below its all-time high of -$53.50 million, reached on 31 December 2013.ATXS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$649.17 M
-$24.53 M-3.93%
30 September 2024
Summary:
Astria Therapeutics quarterly retained earnings is currently -$649.17 million, with the most recent change of -$24.53 million (-3.93%) on 30 September 2024. Over the past year, it has dropped by -$100.04 million (-18.22%). ATXS quarterly retained earnings is now -761.19% below its all-time high of -$75.38 million, reached on 31 December 2014.ATXS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATXS Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.4% | -18.2% |
| 3 y3 years | -122.5% | -45.5% |
| 5 y5 years | -194.2% | -199.2% |
ATXS Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -122.5% | at low | -45.5% | at low |
| 5 y | 5 years | -194.2% | at low | -199.2% | at low |
| alltime | all time | -985.2% | at low | -761.2% | at low |
Astria Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$649.17 M(+3.9%) |
| June 2024 | - | -$624.63 M(+4.0%) |
| Mar 2024 | - | -$600.46 M(+3.4%) |
| Dec 2023 | -$580.53 M(+14.4%) | -$580.53 M(+5.7%) |
| Sept 2023 | - | -$549.12 M(+3.3%) |
| June 2023 | - | -$531.40 M(+2.4%) |
| Mar 2023 | - | -$518.83 M(+2.2%) |
| Dec 2022 | -$507.64 M(+11.4%) | -$507.64 M(+2.7%) |
| Sept 2022 | - | -$494.38 M(+2.5%) |
| June 2022 | - | -$482.38 M(+2.4%) |
| Mar 2022 | - | -$471.13 M(+3.4%) |
| Dec 2021 | -$455.81 M(+74.7%) | -$455.81 M(+2.1%) |
| Sept 2021 | - | -$446.32 M(+1.8%) |
| June 2021 | - | -$438.45 M(+1.7%) |
| Mar 2021 | - | -$430.98 M(+65.2%) |
| Dec 2020 | -$260.90 M(+16.7%) | -$260.90 M(+3.6%) |
| Sept 2020 | - | -$251.92 M(+4.5%) |
| June 2020 | - | -$241.06 M(+4.1%) |
| Mar 2020 | - | -$231.55 M(+3.6%) |
| Dec 2019 | -$223.60 M | -$223.60 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | -$216.99 M(+3.1%) |
| June 2019 | - | -$210.47 M(+3.5%) |
| Mar 2019 | - | -$203.34 M(+3.1%) |
| Dec 2018 | -$197.30 M(+15.1%) | -$197.30 M(+3.2%) |
| Sept 2018 | - | -$191.24 M(+3.1%) |
| June 2018 | - | -$185.56 M(+3.6%) |
| Mar 2018 | - | -$179.09 M(+4.5%) |
| Dec 2017 | -$171.43 M(+19.0%) | -$171.43 M(+3.3%) |
| Sept 2017 | - | -$165.94 M(+4.4%) |
| June 2017 | - | -$158.92 M(+4.6%) |
| Mar 2017 | - | -$151.95 M(+5.5%) |
| Dec 2016 | -$144.07 M(+33.4%) | -$144.07 M(+6.5%) |
| Sept 2016 | - | -$135.29 M(+6.6%) |
| June 2016 | - | -$126.87 M(+8.0%) |
| Mar 2016 | - | -$117.43 M(+8.7%) |
| Dec 2015 | -$108.01 M(+43.3%) | -$108.01 M(+9.8%) |
| Sept 2015 | - | -$98.40 M(+9.4%) |
| June 2015 | - | -$89.92 M(+9.8%) |
| Mar 2015 | - | -$81.88 M(+8.6%) |
| Dec 2014 | -$75.38 M(+40.9%) | -$75.38 M |
| Dec 2013 | -$53.50 M | - |
FAQ
- What is Astria Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Astria Therapeutics?
- What is Astria Therapeutics annual retained earnings year-on-year change?
- What is Astria Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Astria Therapeutics?
- What is Astria Therapeutics quarterly retained earnings year-on-year change?
What is Astria Therapeutics annual retained earnings?
The current annual retained earnings of ATXS is -$580.53 M
What is the all time high annual retained earnings for Astria Therapeutics?
Astria Therapeutics all-time high annual retained earnings is -$53.50 M
What is Astria Therapeutics annual retained earnings year-on-year change?
Over the past year, ATXS annual retained earnings has changed by -$72.89 M (-14.36%)
What is Astria Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ATXS is -$649.17 M
What is the all time high quarterly retained earnings for Astria Therapeutics?
Astria Therapeutics all-time high quarterly retained earnings is -$75.38 M
What is Astria Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ATXS quarterly retained earnings has changed by -$100.04 M (-18.22%)